Integral Diagnostics Ltd.(AU:IDX)
A$1.72-0.00 (-1.44%)
AU:IDX
Integral Diagnostics Ltd. financials statements
A$1.72
At close:-0.00 (-1.44%)
Want to see AU:IDX full AI Analyst Report?
Integral Diagnostics Ltd. (IDX) Ratios
43 Followers
Integral Diagnostics Ltd. Ratios
AU:IDX's free cash flow for Q4 2026 was AU$37.62M. For the 2026 fiscal year, AU:IDX's free cash flow was decreased by AU$-24.78M and operating cash flow was AU$62.40M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.67 | 0.68 | 0.86 | 0.82 | 1.96 |
| Quick Ratio | 0.65 | 0.66 | 0.84 | 0.80 | 1.95 |
| Cash Ratio | 0.35 | 0.37 | 0.49 | 0.41 | 1.53 |
| Solvency Ratio | 0.12 | 0.09 | -0.03 | 0.15 | 0.12 |
| Operating Cash Flow Ratio | 0.64 | 0.52 | 0.76 | 0.85 | 0.46 |
| Short-Term Operating Cash Flow Coverage | 4.44 | 0.00 | 0.00 | 29.10 | 6.78 |
| Net Current Asset Value | AU$ -679.32M | AU$ -637.25M | AU$ -367.75M | AU$ -397.58M | AU$ -277.55M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.41 | 0.41 | 0.48 | 0.44 | 0.44 |
| Debt-to-Equity Ratio | 0.88 | 0.84 | 1.18 | 0.98 | 0.98 |
| Debt-to-Capital Ratio | 0.47 | 0.46 | 0.54 | 0.49 | 0.50 |
| Long-Term Debt-to-Capital Ratio | 0.34 | 0.33 | 0.42 | 0.37 | 0.38 |
| Financial Leverage Ratio | 2.16 | 2.06 | 2.47 | 2.25 | 2.25 |
| Debt Service Coverage Ratio | 2.41 | 2.91 | 0.38 | 4.20 | 3.88 |
| Interest Coverage Ratio | 2.03 | 2.00 | 1.89 | 2.19 | 3.67 |
| Debt to Market Cap | 0.49 | 0.44 | 0.36 | 0.29 | 0.34 |
| Interest Debt Per Share | 1.69 | 2.00 | 1.62 | 1.65 | 1.68 |
| Net Debt to EBITDA | 3.84 | 5.88 | 25.88 | 3.57 | 3.12 |
| Profitability Margins | |||||
| Gross Profit Margin | 21.37% | 95.52% | 95.12% | 22.21% | 23.37% |
| EBIT Margin | 8.58% | 4.97% | -7.40% | 11.13% | 9.21% |
| EBITDA Margin | 18.01% | 14.46% | 2.58% | 21.07% | 19.49% |
| Operating Profit Margin | 8.58% | 9.17% | 8.98% | 9.12% | 10.72% |
| Pretax Profit Margin | 4.07% | 1.86% | -12.15% | 7.04% | 6.33% |
| Net Profit Margin | 2.78% | 0.75% | -12.92% | 5.69% | 4.07% |
| Continuous Operations Profit Margin | 2.79% | 0.77% | -12.91% | 5.69% | 4.07% |
| Net Income Per EBT | 68.31% | 40.09% | 106.35% | 80.88% | 64.28% |
| EBT Per EBIT | 47.46% | 20.26% | -135.35% | 77.14% | 59.09% |
| Return on Assets (ROA) | 1.50% | 0.33% | -8.16% | 2.98% | 1.86% |
| Return on Equity (ROE) | 3.24% | 0.67% | -20.12% | 6.71% | 4.21% |
| Return on Capital Employed (ROCE) | 5.16% | 4.47% | 6.42% | 5.31% | 5.47% |
| Return on Invested Capital (ROIC) | 3.48% | 1.82% | 6.28% | 4.26% | 3.47% |
| Return on Tangible Assets | 3.58% | 0.83% | -17.58% | -31.21% | 29.17% |
| Earnings Yield | 2.94% | 0.60% | -10.04% | 3.28% | 2.30% |
| Efficiency Ratios | |||||
| Receivables Turnover | 22.12 | 22.04 | 19.19 | 18.43 | 14.75 |
| Payables Turnover | 33.91 | 1.37 | 2.25 | 32.89 | 31.62 |
| Inventory Turnover | 181.31 | 11.17 | 13.88 | 185.25 | 217.48 |
| Fixed Asset Turnover | 1.65 | 1.34 | 1.74 | 1.56 | 1.55 |
| Asset Turnover | 0.54 | 0.44 | 0.63 | 0.52 | 0.46 |
| Working Capital Turnover Ratio | -16.67 | -21.74 | -34.18 | 14.09 | 8.39 |
| Cash Conversion Cycle | 7.75 | -217.88 | -116.74 | 10.68 | 14.88 |
| Days of Sales Outstanding | 16.50 | 16.56 | 19.02 | 19.80 | 24.75 |
| Days of Inventory Outstanding | 2.01 | 32.69 | 26.29 | 1.97 | 1.68 |
| Days of Payables Outstanding | 10.76 | 267.12 | 162.05 | 11.10 | 11.54 |
| Operating Cycle | 18.52 | 49.25 | 45.31 | 21.77 | 26.43 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.26 | 0.24 | 0.28 | 0.31 | 0.18 |
| Free Cash Flow Per Share | 0.12 | 0.05 | 0.18 | 0.12 | 0.04 |
| Dividend Paid and CapEx Coverage Ratio | 1.26 | 0.98 | 1.75 | 1.26 | 0.76 |
| Capital Expenditure Coverage Ratio | 1.92 | 1.23 | 2.77 | 1.62 | 1.34 |
| Operating Cash Flow Coverage Ratio | 0.16 | 0.13 | 0.19 | 0.20 | 0.11 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.12 | 0.14 | 0.16 | 0.10 |
| Free Cash Flow Yield | 6.11% | 1.80% | 6.99% | 3.59% | 1.47% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 34.01 | 167.11 | -9.96 | 30.48 | 43.44 |
| Price-to-Sales (P/S) Ratio | 0.95 | 1.24 | 1.29 | 1.73 | 1.77 |
| Price-to-Book (P/B) Ratio | 1.10 | 1.12 | 2.00 | 2.05 | 1.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 16.35 | 55.58 | 14.30 | 27.83 | 67.99 |
| Price-to-Operating Cash Flow Ratio | 7.83 | 10.56 | 9.14 | 10.69 | 17.10 |
| Price-to-Earnings Growth (PEG) Ratio | 0.12 | -1.58 | 0.03 | 0.53 | -0.77 |
| Enterprise Value Multiple | 9.10 | 14.47 | 75.86 | 11.80 | 12.19 |
| Enterprise Value | 1.29B | 1.31B | 917.91M | 1.09B | 852.19M |
| EV to EBITDA | 9.10 | 14.47 | 75.86 | 11.80 | 12.19 |
| EV to Sales | 1.64 | 2.09 | 1.95 | 2.49 | 2.38 |
| EV to Free Cash Flow | 28.32 | 93.61 | 21.71 | 39.91 | 91.34 |
| EV to Operating Cash Flow | 13.56 | 17.78 | 13.87 | 15.33 | 22.97 |
| Tangible Book Value Per Share | -0.44 | -0.55 | -0.42 | -2.35 | -1.84 |
| Shareholders’ Equity Per Share | 1.81 | 2.26 | 1.29 | 1.60 | 1.66 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.31 | 0.59 | -0.06 | 0.18 | 0.35 |
| Revenue Per Share | 2.12 | 2.05 | 2.01 | 1.89 | 1.71 |
| Net Income Per Share | 0.06 | 0.02 | -0.26 | 0.11 | 0.07 |
| Tax Burden | 0.68 | 0.40 | 1.06 | 0.81 | 0.64 |
| Interest Burden | 0.47 | 0.37 | 1.64 | 0.63 | 0.69 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.13 | 0.67 | 0.65 | 0.65 | 0.63 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | -0.00 |
| Income Quality | 4.34 | 15.79 | -1.09 | 2.85 | 2.54 |
Currency in AUD
